ADC Therapeutics (ADCT) to Report Q2 Earnings on August 13
ADCT Adc Therapeutics SA
$1.60 +6.67%
View chart & analysis → - 1ADC Therapeutics (ADCT) Q2 earnings scheduled for release on August 13, 2026
- 2Consensus revenue of $19.38 million and EPS of -$0.21 expected
- 3Upside potential of 125.42% vs. current price $1.18 based on GF Value of $2.66
Source GuruFocus.com +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.